Success in oral insulin study

Israeli bio-tech Oramed has announced that its Phase 2a clinical trial for its ORMD-0801 oral insulin capsule for the treatment of type 2 diabetes met all primary and secondary endpoints. The Phase 2b study will be carried out later this year, and Oramed plans a Phase 2a study for Type 1 diabetes.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *